How much cash does Carlsmed, Inc. Common Stock generate?

Carlsmed, Inc. Common Stock (CARL) generated -$33.8M in operating cash flow over the trailing twelve months.

What is Carlsmed, Inc. Common Stock's free cash flow?

After $638.0K of capital expenditures, Carlsmed, Inc. Common Stock's free cash flow was -$34.5M over the trailing twelve months.

Where does Carlsmed, Inc. Common Stock's cash flow data come from?

Every line is extracted from Carlsmed, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Carlsmed, Inc. Common Stock CARL Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25
Net income	-$29.63M-22.2%
Depreciation and amortization	$281K—
Stock-based compensation	$1.93M—
Change in accounts receivable	$5.01M—
Change in inventories	$2.69M—
Change in accounts payable	$2.32M+682%
Change in accrued liabilities	$627K—
Change in other assets	$2.34M—
Other working capital changes	-$17K—
Change in operating lease liabilities	-$313K—
Net cash from operating activities	-$28.98M—
Capital expenditures	$642K—
Purchases of investments	$24M—
Net cash from investing activities	-$25.48M—
Proceeds from issuance of common stock	$205K—
Payment of debt issuance costs	——
Proceeds from issuance of preferred stock	——
Net cash from financing activities	——
Net increase (decrease) in cash	——
Write-off of customer financing receivable	$504K+37.0%
Increase Decrease In Deferred Compensation	$2.49M—
Operating lease liabilities	-$313K—
Increase (Decrease) in Prepaid Expense and Other Assets	$2.34M—
Inventory write-downs	$1.84M—
Noncash Interest	$206K—
Noncash Lease Expense	$536K—
Payments For Software	$715K—
Payments to Acquire Short-Term Investments	$24M—
Payment Of Issuance Costs Related To Term Loan Modification	$50K—
Payments For Deferred Initial Public Offering Costs	$5.41M—
Net proceeds from sales of subsidiary shares	$93.47M—
Proceeds From Issuance Of Convertible Preferred Stock	——
Accrued payables for capital expenditures	$41K—
Capitalized Internal Use Software In Accounts Payable And Accrued Liabilities	——
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction	$0-100%
Fair Value Adjustment Of Warrants	$335K+133%
Increase Decrease In Operating Lease Liability	-$313K—
Reclassification Of Financial Commitment Asset To Debt Discount	$69K—
Leased assets obtained in exchange for operating lease liabilities	$593K—
Unpaid Deferred Offering And Issuance Costs	——
Vesting Of Early Exercised Common Stock Options	$42K—
Financed construction projects	$127K—
Cash paid for interest, net of amounts capitalized	$1.2M+7.4%
Free cash flow	-$29.62M—
Free cash flow	-$29.62M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Carlsmed, Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Carlsmed, Inc. Common Stock generate?: Carlsmed, Inc. Common Stock (CARL) generated -$33.8M in operating cash flow over the trailing twelve months.
What is Carlsmed, Inc. Common Stock's free cash flow?: After $638.0K of capital expenditures, Carlsmed, Inc. Common Stock's free cash flow was -$34.5M over the trailing twelve months.
Where does Carlsmed, Inc. Common Stock's cash flow data come from?: Every line is extracted from Carlsmed, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.